Showing 4341-4350 of 6808 results for "".
- Bernie Sanders Urges Treasury to Block Pfizer-AGN Mergerhttps://practicaldermatology.com/news/bernie-sanders-urges-treasury-to-block-pfizer-agn-merger/2458642/Democratic presidential hopeful Bernie Sanders is urging the US Treasury to prevent the Pfizer-Allergan deal, according to media reports. Calling it a ‘tax scam” in a
- New Research Suggests Why PD-1 Blockers Don't Work for All Melanoma Patientshttps://practicaldermatology.com/news/new-research-suggests-why-pd-1-blockers-dont-work-for-all-melanoma-patients/2458645/Immunotherapy using anti-PD-1 antibodies has been a game change for metastatic melanoma patients, but 60 to 70 percent of patients’ melanoma tumors are resistant to the anti-PD-1 antibodies. Now new research out of UCLA suggests that patterns of gene
- Do the FDA's Proposed Regulations on Tanning Bed Use Go Far Enough?https://practicaldermatology.com/news/do-the-fdas-proposed-regulations-on-tanning-bed-use-go-far-enough/2458646/As the comment period on the US Food and Drug Administration’s proposal to restrict tanning bed use winds down, researchers are weighing in on the proposal's merits and potential shortfalls. Investigators
- Dark Beer? Green Cabbage? The Scoop on St. Patrick's Day's Hidden Beauty Secretshttps://practicaldermatology.com/news/dark-beer-green-cabbage-the-scoop-on-st-patricks-days-hidden-beauty-secrets/2458647/It’s easy to be green on St. Patrick’s day (March 17th), but many skin care companies are now carrying this torch 365 days a year. And going green isn’t the only St. Paddy’s day tradition that promises beauty benefits. Companies such as
- Blood Test May ID Early Signs of Metastatic Melanoma Relapsehttps://practicaldermatology.com/news/blood-test-may-id-early-signs-of-metastatic-melanoma-relapse/2458653/A new blood test may be able to detect metatstatic melanoma relapse earlier than is currently possible, according to a study published in the journal Cancer Discovery. Scientists from the Cancer Research UK
- Dr. Henry Lim Begins Term as 2016 President-Elect of AADhttps://practicaldermatology.com/news/dr-henry-lim-begins-term-as-president-elect-of-aad/2458660/Congrats … Henry Lim, M.D., chair of the Department of Dermatology at Henry Ford Hospital is now the president-elect of the American Academy of Dermatology (AAD). In March 2017, he will become president and serve for one year. Dr. Lim is board certified in dermat
- Medical Professionals, Practical Dermatology® Board Members, Recognized for Outstanding Work in Psoriatic Disease Fieldhttps://practicaldermatology.com/news/medical-professionals-practical-dermatology-board-members-recognized-for-outstanding-work-in-psoriatic-disease-field/2458661/Nominated by patients and colleagues, recipients of the first annual National Psoriasis Foundation Medical Professionals Awards exemplify the outstanding work being done in the psoriatic disease
- Cipher Pharmaceuticals Appoints New President and General Manager of US Businesshttps://practicaldermatology.com/news/cipher-pharmaceuticals-appoints-new-president-and-general-manager-of-us-business/2458662/Cipher Pharmaceuticals Inc. named Ralph Bohrer as President and General Manager of its US subsidiary. Mr. Bohrer is a seasoned pharmaceutical executive with 30 years of experience in sales and marketing leadership for growing dermatology companies. Prior to
- Provectus Biopharmaceuticals Announces Leadership Changeshttps://practicaldermatology.com/news/provectus-biopharmaceuticals-announces-leadership-changes/2458674/Provectus Biopharmaceuticals, Inc. detailed several leadership changes following the resignation of one of its Co-Founders and its Chairman and CEO, H. Craig Dees, PhD. The Provectus Board of Directors accepted the resignation of Dr. Dees, which he submitted due to personal and health reasons, in
- Cipher Launches Bionect Foamhttps://practicaldermatology.com/news/cipher-launches-bionect-foam/2458678/Cipher Pharmaceuticals’ prescription topical Bionect® is now available in the US in a lightweight foam preparation that holds its shape until application. The company says the for